COVID-19 Vaccine

About Vaccizone

Vaccizone is a private, pre-clinical stage biotech founded in 2020 and headquartered in London, with significant R&D operations in Istanbul. The company's proprietary ASC technology platform utilizes a modified inflammasome complex (ASC speck) to deliver antigens, offering improved stability, enhanced delivery to antigen-presenting cells, and intrinsic adjuvant properties. Its initial pipeline includes programs for COVID-19, melanoma, and veterinary vaccines, positioning it to address significant unmet needs in vaccine development and immunotherapy.

About Rational Vaccines

Rational Vaccines is a private, pre-revenue biotech firm founded in 2015, headquartered in Boston, USA, targeting the vast unmet medical need in herpes simplex virus infections. The company's core approach involves a proprietary platform for live-attenuated vaccine design, with its lead program focused on genital herpes. While primarily targeting HSV, the company has also indicated exploration of its technology for COVID-19, though its primary focus and stated goal is the eradication of herpes.

About Recbio Technology

A Chinese vaccine innovator with proprietary adjuvant and protein engineering platforms, advancing late-stage HPV and shingles vaccines.

Therapeutic Areas